Drs. Gunda Georg & Vadim Gurvich - HealthTalk

Institute for Therapeutics Discovery & Development (ITDD) Directors Gunda Georg and Vadim Gurvich were featured in the HealthTalk story, "New $8.3M NIH contract to advance hormone-free birth control research at University of Minnesota."

ITDD - NIH Contract

Institute for Therapeutics Discovery & Development (ITDD) faculty will receive $8.3 million from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to investigate pharmaceutical alternatives to existing birth control methods. The primary goal of the five-year research contract is to both develop new non-hormonal male and female birth control drug targets and expand on existing targets.

Dr. Dan Harki - Engebretson/Bighley Grant

A $23,000 Engebretson/Bighley Drug Design & Development Grant was awarded to faculty member Dan Harki for his project "Discovery of APOBEC3B Small Molecule Inhibitors."

Dr. David Ferguson - HealthTalk Story

Professor David Ferguson is featured in the October 16 Academic Health Center HealthTalk story "Expert Perspective: Workout enhancer contains meth-like stimulant."

Dr. David Ferguson - MN Daily article

Professor David Ferguson was quoted in the September 19 Minnesota Daily article "Molly drug use more common than U think."

Maggie Olson - 2013-14 ACS Predoctoral Fellowship

Graduate student Maggie Olson has been selected to receive a Division of Medicinal Chemistry Predoctoral Fellowship for 2013-14 from the American Chemical Society. Maggie is a member of Dan Harki's lab.

Dr. Gunda Georg - Grant for Non-hormonal Contraceptive Research

Medicinal Chemistry Department Head and Institute for Therapeutics Discovery & Development Director Gunda Georg will receive $8.3 million over five years from the National Institute for Child Health and Human Development to design, synthesize, and evaluate non-hormonal contraceptives for men and women.